Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2003
11/20/2003CA2485083A1 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof
11/20/2003CA2484968A1 Substituted piperazine as melanocortin receptors ligands
11/19/2003EP1362850A1 Oxime ether compound and agricultural or horticultural bactericide
11/19/2003EP1362844A1 Benzylamine analogue
11/19/2003EP1362839A2 Liquid crystal composition having a delta-epsilon- of not less than zero and liquid crystal display device
11/19/2003EP1362590A1 Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
11/19/2003EP1362047A2 Indazolyl-substituted pyrroline compounds as kinase inhibitors
11/19/2003EP1362046A1 Substituted pyrimidinone derivatives as ligands of integrin receptors
11/19/2003EP1362045A2 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
11/19/2003EP1362044A1 Phthalazinone-piperidino-derivatives as pde4 inhibitors
11/19/2003EP1362041A1 Aryl carbamate derivatives, preparation and use thereof
11/19/2003EP1362039A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1362033A1 Pyridine matrix metalloproteinase inhibitors
11/19/2003EP1362027A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
11/19/2003EP1361873A2 Matrix metalloproteinase inhibitors
11/19/2003EP1003738B1 Bicyclic compounds as ligands for 5-ht1 receptors
11/19/2003EP0991624B1 Phenylalkyl derivatives with thrombin-inhibiting effect
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003EP0852226B1 Pyrimidine derivatives
11/19/2003EP0809499B1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
11/19/2003CN1457339A Chemokine receptor binding heterocyclic compounds
11/19/2003CN1128147C 3-oxo-2(H)-1,2,4-triazine deriatives as ligands of 5HT1A receptors
11/19/2003CN1128141C 1,2,4-triazine-3,5-dione derivatives, their production and use thereof
11/18/2003US6649770 Exhibit superior hydrolytic stability, handling and storage stability as well as good resistance to extractability when present in stabilized composition
11/18/2003US6649768 Converting, in dimethyl sulfoxide, 3-haloacetylpyridine to glyoxal compound, reacting with ammonia and aldehyde to produce 3-(4-imidazolyl)pyridine compound
11/18/2003US6649763 Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof
11/18/2003US6649760 Substituted phenyluracils
11/18/2003US6649638 Prenylation inhibitors and methods of their synthesis and use
11/18/2003US6649636 Cyclooxygenase inhibitors
11/18/2003US6649635 Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders
11/18/2003US6649634 Use in treating diabetes, hyperglycemia, hypercholesterolemia, hypertension, hyperinsulinemias, hyperlipidemia, atherosclerosis and myocardial ischemia in mammals
11/18/2003US6649633 Nicotinamide biaryl derivatives useful as inhibitors of PDE4 isozymes
11/18/2003US6649628 Retinopathy, neuropathy and nephropathy treatment; antidiabetic agents
11/18/2003US6649627 N-Substituted with 1- (pyrid-2-yl)-piperidine-4-yl radical; gastrointestinal and psychological disorder treatment; antidiabetic tocolytic, and antidepressant agents; irritable bowel syndrome, glaucoma and dysmenorrhoea
11/18/2003US6649626 Stimulants of gamma -aminobutyric acid receptors; psychological disorders
11/18/2003US6649623 Administering tetrahydropiperidine derivative; antidiabetic agents; hyperlipemia treatment; hypotensive agents
11/18/2003US6649622 Treating diabetes, especially Type II diabetes
11/18/2003US6649620 Quinoline and quinazoline compounds useful in therapy
11/18/2003US6649619 Compounds
11/18/2003US6649618 Substituted amidoalkyl-uracils and their use
11/18/2003US6649616 For therapy and prophylaxis of cardiovascular disorders caused by ischaemia
11/18/2003US6649611 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes).
11/18/2003US6649609 Benzimidazole derivatives and pharmaceutical compositions comprising these compounds
11/18/2003US6649608 Cyclin-dependent serine/threonine and focal adhesion kinase inhibitors
11/18/2003US6649604 Analgesics; antidiabetic agents; antiinflamamtory agents
11/18/2003US6649603 For therapy of metabolic disorders related to insulin resistance or hyperglycemia
11/18/2003US6649589 Blocking tumor necrosis factor activity with soluble cytokine receptor, monoclonal antibody or tetracycline derivative
11/13/2003WO2003093297A2 Protein kinase modulators and methods of use
11/13/2003WO2003093268A1 7-aminoimidazotriazones
11/13/2003WO2003093263A1 Substituted imidazole derivatives: gabaa receptor ligands
11/13/2003WO2003093261A1 Phthalazinone derivatives
11/13/2003WO2003093245A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists
11/13/2003WO2003093244A1 Substituted (thioxo)carbonylamino phenyl uraciles
11/13/2003WO2003093242A2 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
11/13/2003WO2003093241A1 Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
11/13/2003WO2003093240A1 Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same
11/13/2003WO2003093237A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors
11/13/2003WO2003093236A1 1-(pyrid-2-yl)-piperazine compounds as metabotropic glutamate receptor inhibitor
11/13/2003WO2003093235A1 Carboxylic acid amides
11/13/2003WO2003093234A1 Melanocortin receptor ligands
11/13/2003WO2003093231A2 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
11/13/2003WO2003092690A1 N-acyl piperidine derivatives for use as melanocortin receptor ligands in the treatment of feeding disorders
11/13/2003WO2003092688A2 Heterocyclic derivatives as opioid modulators
11/13/2003WO2003092686A1 Inhibitors of histone deacetylase
11/13/2003WO2003092678A1 1-substituted imidazole derivatives as nos inhibitors
11/13/2003WO2003092670A1 Bombesin antagonists
11/13/2003WO2003092380A1 2,6 substituted pyridine-3-carbonyl derivatives serving as plant protection agents having herbicidal action
11/13/2003WO2003092374A2 Pesticidal heterocycles
11/13/2003WO2003076417A3 Oxo-azabicyclic compounds
11/13/2003WO2003066621A8 Piperidine derivatives and their use as antagonists of tachykinins
11/13/2003WO2003057688A3 Oxo or oxy-pyridine compounds as 5-ht4 receptor modulators
11/13/2003WO2003057672A3 Tetrahydroquinoline analogues as muscarinic agonists
11/13/2003WO2003057165A3 COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF AMYLOID-β PEPTIDE-RELATED DISORDERS
11/13/2003WO2003053344A3 Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
11/13/2003WO2003041644A3 Method to treat cystic fibrosis
11/13/2003WO2003031407A3 β-LACTAMYL VASOPRESSIN VlaANTAGONISTS
11/13/2003WO2003029221A8 Tetrahydroisochinolines, their production and the use thereof as analgesics
11/13/2003WO2003029200A3 Compounds useful as reversible inhibitors of cysteine proteases
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2003015703A3 Compositions and methods relating to novel benzodiazepine compounds and targets thereof
11/13/2003WO2002096879A9 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
11/13/2003WO2002077609A3 Identification of compounds for the treatment or prevention of proliferative diseases
11/13/2003WO2002055486A3 Triazene compounds and use thereof
11/13/2003WO2002032874A8 Substituted heterocyclic compounds for treating multidrug resistance
11/13/2003WO2002032868A8 2-substituted heterocyclic compounds and their use in treating multidrug resistance
11/13/2003WO2001040188A8 Curcumin analogues for treating cancer
11/13/2003US20030212276 Process for the preparation of 7-substituted-3 quinolinecarbonitriles
11/13/2003US20030212275 Process for the preparation of chemical compounds
11/13/2003US20030212274 Salt formation using metal alkoxide
11/13/2003US20030212269 Kinase inhibitor; antitumor agents, psoriasis, skin disorders, antiarthritic agents
11/13/2003US20030212141 Serotonin antagonists
11/13/2003US20030212120 Compositions comprising a substituted benzimidazole useful for treating immunomediated inflammatory disorders
11/13/2003US20030212113 Novel aromatic compounds and poly(oxyalkylene) containing aromatic compounds possessing antibacterial, antifungal or antitumor activity
11/13/2003US20030212103 Anticancer agents; antiproliferative agents
11/13/2003US20030212101 Respiratory system disorders; antiinflammatory agents; psychological disorders
11/13/2003US20030212097 Osteoporosis, antiarthrtic agents; antitumor agents
11/13/2003US20030212094 Novel cyclic amide derivatives
11/13/2003US20030212093 Imidazonaphthyridines
11/13/2003US20030212089 Arylindenopyridines and related therapeutic and prophylactic methods
11/13/2003US20030212084 Naphthrydine compounds and their azaisosteric analogues as antibacterials
1 ... 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 ... 1080